chr11-93784708-C-G

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_004268.5(MED17):​c.195C>G​(p.Gly65Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.62 in 1,548,836 control chromosomes in the GnomAD database, including 303,143 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G65G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.56 ( 25261 hom., cov: 33)
Exomes 𝑓: 0.63 ( 277882 hom. )

Consequence

MED17
NM_004268.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.202

Publications

22 publications found
Variant links:
Genes affected
MED17 (HGNC:2375): (mediator complex subunit 17) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008]
MED17 Gene-Disease associations (from GenCC):
  • infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 11-93784708-C-G is Benign according to our data. Variant chr11-93784708-C-G is described in ClinVar as [Benign]. Clinvar id is 129600.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.202 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED17NM_004268.5 linkc.195C>G p.Gly65Gly synonymous_variant Exon 1 of 12 ENST00000251871.9 NP_004259.3 Q9NVC6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED17ENST00000251871.9 linkc.195C>G p.Gly65Gly synonymous_variant Exon 1 of 12 1 NM_004268.5 ENSP00000251871.3 Q9NVC6-1
ENSG00000284057ENST00000638767.1 linkc.756C>G p.Gly252Gly synonymous_variant Exon 8 of 19 5 ENSP00000492220.1 A0A1W2PRB8

Frequencies

GnomAD3 genomes
AF:
0.559
AC:
84705
AN:
151528
Hom.:
25248
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.334
Gnomad AMI
AF:
0.574
Gnomad AMR
AF:
0.704
Gnomad ASJ
AF:
0.590
Gnomad EAS
AF:
0.748
Gnomad SAS
AF:
0.594
Gnomad FIN
AF:
0.668
Gnomad MID
AF:
0.570
Gnomad NFE
AF:
0.627
Gnomad OTH
AF:
0.585
GnomAD2 exomes
AF:
0.645
AC:
99008
AN:
153594
AF XY:
0.641
show subpopulations
Gnomad AFR exome
AF:
0.330
Gnomad AMR exome
AF:
0.793
Gnomad ASJ exome
AF:
0.583
Gnomad EAS exome
AF:
0.750
Gnomad FIN exome
AF:
0.669
Gnomad NFE exome
AF:
0.632
Gnomad OTH exome
AF:
0.615
GnomAD4 exome
AF:
0.627
AC:
875994
AN:
1397190
Hom.:
277882
Cov.:
75
AF XY:
0.627
AC XY:
432320
AN XY:
689594
show subpopulations
African (AFR)
AF:
0.324
AC:
10406
AN:
32156
American (AMR)
AF:
0.780
AC:
27890
AN:
35768
Ashkenazi Jewish (ASJ)
AF:
0.585
AC:
14725
AN:
25178
East Asian (EAS)
AF:
0.763
AC:
27803
AN:
36452
South Asian (SAS)
AF:
0.598
AC:
47600
AN:
79556
European-Finnish (FIN)
AF:
0.658
AC:
28519
AN:
43352
Middle Eastern (MID)
AF:
0.588
AC:
3236
AN:
5504
European-Non Finnish (NFE)
AF:
0.629
AC:
680129
AN:
1081094
Other (OTH)
AF:
0.614
AC:
35686
AN:
58130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
18936
37871
56807
75742
94678
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18302
36604
54906
73208
91510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.559
AC:
84744
AN:
151646
Hom.:
25261
Cov.:
33
AF XY:
0.564
AC XY:
41815
AN XY:
74076
show subpopulations
African (AFR)
AF:
0.334
AC:
13802
AN:
41370
American (AMR)
AF:
0.704
AC:
10746
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.590
AC:
2046
AN:
3466
East Asian (EAS)
AF:
0.748
AC:
3840
AN:
5132
South Asian (SAS)
AF:
0.596
AC:
2874
AN:
4826
European-Finnish (FIN)
AF:
0.668
AC:
7017
AN:
10500
Middle Eastern (MID)
AF:
0.568
AC:
166
AN:
292
European-Non Finnish (NFE)
AF:
0.627
AC:
42503
AN:
67788
Other (OTH)
AF:
0.582
AC:
1229
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1815
3630
5444
7259
9074
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.576
Hom.:
6639
Bravo
AF:
0.553
Asia WGS
AF:
0.609
AC:
2118
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly Benign:4
Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 18, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 28, 2012
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
13
DANN
Benign
0.70
PhyloP100
-0.20
PromoterAI
-0.014
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7116967; hg19: chr11-93517874; COSMIC: COSV52599609; COSMIC: COSV52599609; API